EP.11D.02 An Investigator-Initiated Phase II Study of Combination Treatment of Nivolumab and TM5614, A PAI-1 Inhibitor for Previously Treated NSCLC
Author:
T. Masuda,T. Hirata,T. Sakamoto,Y. Tsubata,E. Ichihara,T. Kozuki,H. Shoda,E. Fukagawa,T. Yoshida,M. Fukutani,K. Tsuji-Takayama,Y. Orihashi,N. Hattori
Publication:
Journal of Thoracic Oncology
Copyright © 2024 Published by Elsevier Inc.